Size-transformable antigen-presenting cell–mimicking nanovesicles potentiate effective cancer immunotherapy

Artificial antigen-presenting cells (aAPCs) can stimulate CD8(+) T cell activation. While nanosized aAPCs (naAPCs) have a better safety profile than microsized (maAPCs), they generally induce a weaker T cell response. Treatment with aAPCs alone is insufficient due to the lack of autologous antigen-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Weijing, Deng, Hongzhang, Zhu, Shoujun, Lau, Joseph, Tian, Rui, Wang, Sheng, Zhou, Zijian, Yu, Guocan, Rao, Lang, He, Liangcan, Ma, Ying, Chen, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732193/
https://www.ncbi.nlm.nih.gov/pubmed/33310853
http://dx.doi.org/10.1126/sciadv.abd1631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732193/
https://www.ncbi.nlm.nih.gov/pubmed/33310853
http://dx.doi.org/10.1126/sciadv.abd1631

Ejemplares similares